Bayer Battles Generic Yasmin Hopeful In Fed. Circ.
Bayer Healthcare Pharmaceuticals Inc. sought to persuade the Federal Circuit on Wednesday that it has a valid case to block generics makers from introducing a version of its oral contraceptive Yasmin,...To view the full article, register now.
Already a subscriber? Click here to view full article